People · Operator
Named in public records as an officer, director or promoter · active 2018–2022 · Other, Biotech / Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| ScriptDash Inc. | — | Other | Series D+ | $208.1M | $2.2B | 2018 |
| Alto Pharmacy Holdings, Inc. | — | Biotech / Pharma | Series D+ | $169.7M | $3.1B | 2021 |
Mattieu Gamache-Asselin at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mattieu Gamache-Asselin on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Neil Shah | 2 | 4 |
| James Karraker | 2 | 2 |
| Nathaniel Justin Kan | 1 | 8 |
| Nichola Eliovits | 1 | 4 |
| Kevin Burns | 1 | 4 |
| ROBERT SPINNER | 1 | 4 |
| Josh Breinlinger | 1 | 4 |
| Nathaniel Kan | 1 | 1 |
| Nichola Justin Eliovits | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.